Login / Signup
Christina Larsen
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Small Cell Lung Cancer
Oxidative Stress
Long Noncoding Rna
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Noura J Choudhury
,
W Victoria Lai
,
Alex Makhnin
,
Glenn Heller
,
Juliana Eng
,
Bob T Li
,
Isabel R Preeshagul
,
Fernando C Santini
,
Michael D Offin
,
Kenneth Ng
,
Paul K Paik
,
Christina Larsen
,
Michelle S Ginsberg
,
Yvonne Lau
,
Xinyuan Zhang
,
Marina K Baine
,
Natasha Rekhtman
,
Charles M Rudin
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (17) (2024)
Noura J Choudhury
,
W Victoria Lai
,
Alex Makhnin
,
Glenn Heller
,
Juliana Eng
,
Bob T Li
,
Isabel R Preeshagul
,
Fernando C Santini
,
Michael D Offin
,
Kenneth Ng
,
Paul K Paik
,
Christina Larsen
,
Michelle S Ginsberg
,
Yvonne Lau
,
Xinyuan Zhang
,
Marina K Baine
,
Natasha Rekhtman
,
Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Noura J Choudhury
,
W Victoria Lai
,
Alex Makhnin
,
Glenn Heller
,
Juliana Eng
,
Bob T Li
,
Isabel R Preeshagul
,
Fernando C Santini
,
Michael D Offin
,
Kenneth Ng
,
Paul K Paik
,
Christina Larsen
,
Michelle S Ginsberg
,
Yvonne Lau
,
Xinyuan Zhang
,
Marina K Baine
,
Natasha Rekhtman
,
Charles M Rudin
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)